Trial · NCT07899385
Effects of Scapular Training on Adolescent Boxers
NCT07899385, Not applicable, Recruiting, Istinye University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Scapular Training on Adolescent Boxers. Trials, record NCT07899385. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899385
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Scapular Training on Adolescent Boxers
- NCT number
- NCT07899385
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 52 participants, estimated
- Lead sponsor
- Istinye University
- Conditions
- Sports Physical Therapy
- Interventions
- Scapular Stabilization Exercise Program, Standard Physiotherapy Exercise Program
- First posted
- 2026-10-27
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Scapular Dyskinesis | 6 weeks | Scapular dyskinesis will be assessed using the Scapular Dyskinesis Test (SDT). Participants will perform five repetitions of bilateral shoulder flexion and abduction while holding weights of 1.4 kg or 2.3 kg, depending on body weight. Scapular movements will be visually observed and classified as dyskinesis present or absent based on abnormal scapular motion or asymmetry. |
| Primary | Lateral Scapular Slide Test | 6 weeks | Scapular position and symmetry will be assessed using the Lateral Scapular Slide Test (LSST). The distance between the inferior angle of the scapula and the thoracic spinous processes will be measured bilaterally in three arm positions: 0°, 45°, and 90° of shoulder abduction. Side-to-side differences will be recorded in centimeters (cm). A difference greater than 1.5 cm will be considered indicative of scapular asymmetry. |
| Secondary | Medicine Ball Throw Test | 6 weeks | Upper extremity explosive power will be evaluated using the Medicine Ball Throw Test. Participants will throw a standardized medicine ball forward with maximal effort from a standardized seated or kneeling position. Throwing distance will be recorded in meters (m), with greater distances indicating better explosive upper extremity performance. |
| Secondary | Upper Quarter Y Balance Test | 6 weeks | Upper extremity dynamic balance and stability will be assessed using the Upper Quarter Y Balance Test (UQYBT). Participants will maintain a weight-bearing position on one upper extremity while reaching with the opposite hand in the medial, inferolateral, and superolateral directions. Maximum reach distances will be recorded in centimeters (cm), and a composite score will be calculated. Greater reach distances and composite scores indicate better dynamic stability. |
| Secondary | Closed Kinetic Chain Upper Extremity Stability Test | 6 weeks | Functional upper extremity stability will be evaluated using the Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST). Participants will assume a push-up position with their hands positioned 91.4 cm apart and alternately touch the opposite hand for 15 seconds. The total number of touches completed within 15 seconds will be recorded. Higher scores indicate better upper extremity functional stability and performance. |
| Secondary | 30-Second Repeated Punch Test | 6 weeks | Boxing-specific upper extremity performance will be assessed using the 30-Second Repeated Punch Test. Participants will perform the maximum possible number of straight punches against a standardized punching bag over 30 seconds. The total number of punches will be recorded, with higher values indicating better boxing-specific repetitive punching performance. |
| Secondary | Punch Fatigue Index | 6 weeks | Punching fatigue will be evaluated using three 30-second bouts of maximal straight punches against a punching bag, separated by 30-second rest intervals. The number of punches performed in each bout will be recorded. The Punch Fatigue Index will be calculated as \[(maximum punch count - minimum punch count) / maximum punch count\] × 100. Scores will be expressed as percentages (%), with lower values indicating better maintenance of punching performance across repeated bouts. |
| Secondary | Handgrip Strength | 6 weeks | Handgrip strength will be measured using a hand dynamometer. Participants will be seated with the shoulder adducted, elbow flexed at 90°, and forearm in a neutral position. Three maximal voluntary contractions will be performed, and the highest value will be recorded as the handgrip strength measurement. |
| Secondary | Muscle Strength | 6 weeks | Isometric shoulder abduction, external rotation, serratus anterior and lower trapezius strength will be assessed using a handheld dynamometer. Participants will perform maximal voluntary isometric contractions in standardized testing positions. Muscle strength will be recorded separately for shoulder abduction and external rotation, with higher values indicating greater muscle strength. |
| Secondary | Reaction Time | 6 weeks | Visual reaction time will be assessed using the BlazePod system. Participants will respond as quickly as possible to randomly activated visual stimuli by touching the illuminated pods. Response times will be recorded in milliseconds (ms), with shorter reaction times indicating better neuromotor response performance. |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07899385
GET https://conductscience.org/api/trials/v1/NCT07899385/registered